PL3049073T3 - Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów - Google Patents

Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów

Info

Publication number
PL3049073T3
PL3049073T3 PL14847319T PL14847319T PL3049073T3 PL 3049073 T3 PL3049073 T3 PL 3049073T3 PL 14847319 T PL14847319 T PL 14847319T PL 14847319 T PL14847319 T PL 14847319T PL 3049073 T3 PL3049073 T3 PL 3049073T3
Authority
PL
Poland
Prior art keywords
destabilizing
altering
compositions
dispersing biofilms
biofilms
Prior art date
Application number
PL14847319T
Other languages
English (en)
Inventor
Alexander RICKARD
Nick JAKUBOVICS
Derek S. Samarian
Ethan KOLDERMAN
Original Assignee
The Regents Of The University Of Michigan
University Of Newcastle Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52744423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3049073(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Regents Of The University Of Michigan, University Of Newcastle Upon Tyne filed Critical The Regents Of The University Of Michigan
Publication of PL3049073T3 publication Critical patent/PL3049073T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
PL14847319T 2013-09-24 2014-09-24 Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów PL3049073T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361881762P 2013-09-24 2013-09-24
US201461972920P 2014-03-31 2014-03-31
EP14847319.2A EP3049073B1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms
PCT/US2014/057235 WO2015048146A1 (en) 2013-09-24 2014-09-24 Compositions and method for destabilizing, altering, and dispersing biofilms

Publications (1)

Publication Number Publication Date
PL3049073T3 true PL3049073T3 (pl) 2021-10-25

Family

ID=52744423

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14847319T PL3049073T3 (pl) 2013-09-24 2014-09-24 Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów

Country Status (11)

Country Link
US (2) US20160235698A1 (pl)
EP (3) EP3831374A1 (pl)
CN (3) CN106029062A (pl)
AU (6) AU2014326756B2 (pl)
BR (1) BR112016006584B1 (pl)
DK (1) DK3049073T3 (pl)
ES (1) ES2847388T3 (pl)
MX (1) MX374836B (pl)
PL (1) PL3049073T3 (pl)
WO (1) WO2015048146A1 (pl)
ZA (1) ZA201602797B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
PL3049073T3 (pl) 2013-09-24 2021-10-25 The Regents Of The University Of Michigan Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
AU2019225938A1 (en) * 2018-02-21 2020-10-15 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for new antimicrobial agents with secondary mode of action
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US10927397B2 (en) 2018-10-16 2021-02-23 Sterilex, Llc Compositions, devices and methods for detecting biofilms
BR112021011686A2 (pt) * 2018-12-26 2021-09-08 Colgate-Palmolive Company Papel prebiótico da arginina em bactérias orais benéficas
WO2020139698A1 (en) * 2018-12-26 2020-07-02 Colgate-Palmolive Company Specific co-aggregation inhibition by arginine
US20220071877A1 (en) * 2018-12-26 2022-03-10 Colgate-Palmolive Company Methods of Shifting Biofilm in the Oral Cavity from Pathogenic to Healthy Biofilm
CA3134598A1 (en) * 2019-03-29 2020-10-08 Colgate-Palmolive Company Oral care product
CN110583697B (zh) * 2019-09-20 2021-04-06 浙江工商大学 去除铜绿假单胞菌生物膜用的高效化学生物制剂及其应用
EP4055368A1 (en) 2019-11-08 2022-09-14 Colgate-Palmolive Company Apparatus, system, and method for testing biological samples
WO2021092613A1 (en) * 2019-11-08 2021-05-14 Colgate-Palmolive Company Methods of modifying biofilm
CN111299267B (zh) * 2020-02-12 2021-10-22 上海交通大学 一种基于群感效应的供水管网生物膜控制方法及其应用
WO2023114550A2 (en) * 2021-12-19 2023-06-22 The Trustees Of Columbia University In The City Of New York Engineering bacteria swarm patterns for spatiotemporal information encoding
CN119112857A (zh) * 2024-09-18 2024-12-13 中国科学技术大学 抑制金葡菌生物被膜形成的组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065884B1 (en) 1981-05-27 1986-08-20 Unitika Ltd. Urethral catheter capable of preventing urinary tract infection and process for producing the same
EP1159951A1 (en) * 2000-06-02 2001-12-05 Societe Des Produits Nestle S.A. Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
WO2000066616A1 (en) * 1999-05-03 2000-11-09 Advanced Research & Technology Institute, Inc. METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
AU2001286741A1 (en) * 2000-08-25 2002-03-04 Trustees Of Tufts College Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms
US20100021942A1 (en) * 2008-07-25 2010-01-28 Paul Freemont Cell-free expression system for the detection of bacterial biofilms
AU2009329993B2 (en) * 2008-12-22 2015-10-08 Micropure, Inc Composition and method for reducing demineralization of teeth
MX2012013955A (es) * 2010-06-23 2013-01-24 Colgate Palmolive Co Composiciones terapeuticas bucales.
BR112013010519A2 (pt) 2010-10-27 2016-07-05 Colgate Palmolive Co composição de higiene oral compreendendo arginina e carbonato de cálcio
US9717929B2 (en) * 2010-12-07 2017-08-01 Colgate-Palmolive Company Dentifrice compositions containing calcium silicate and a basic amino acid
JP6038167B2 (ja) * 2011-10-31 2016-12-07 ケーン バイオテク インコーポレーテッド 口腔疾患を予防及び治療する組成物及び方法
BR112014014459A2 (pt) * 2011-12-15 2017-06-13 Colgate Palmolive Co composições para cuidados orais
PL3049073T3 (pl) 2013-09-24 2021-10-25 The Regents Of The University Of Michigan Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów

Also Published As

Publication number Publication date
EP3150715B1 (en) 2018-11-14
MX374836B (es) 2025-03-06
EP3150715A1 (en) 2017-04-05
AU2022271381B2 (en) 2024-08-15
AU2022271381A1 (en) 2022-12-15
AU2021202650A1 (en) 2021-05-27
AU2019271937B2 (en) 2021-01-28
DK3049073T3 (da) 2021-02-01
BR112016006584B1 (pt) 2022-11-29
ES2847388T3 (es) 2021-08-03
EP3049073B1 (en) 2020-11-04
AU2016202002B2 (en) 2017-10-12
EP3049073A1 (en) 2016-08-03
CN115177607A (zh) 2022-10-14
BR112016006584A2 (pt) 2017-08-01
EP3831374A1 (en) 2021-06-09
WO2015048146A1 (en) 2015-04-02
US20160304886A1 (en) 2016-10-20
EP3049073A4 (en) 2017-03-15
MX2016003791A (es) 2017-01-20
US20160235698A1 (en) 2016-08-18
CN110129352A (zh) 2019-08-16
AU2014326756A1 (en) 2016-04-07
US10570401B2 (en) 2020-02-25
CN106029062A (zh) 2016-10-12
AU2024264692A1 (en) 2024-12-05
AU2021202650B2 (en) 2022-09-08
AU2014326756B2 (en) 2019-08-29
AU2016202002A1 (en) 2016-04-21
AU2019271937A1 (en) 2019-12-19
ZA201602797B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
ZA201602797B (en) Compositions and method for destabilizing, altering, and dispersing biofilms
GB201319525D0 (en) Composition
EP3071295A4 (en) Anti-infective methods, compositions, and devices
DK3027701T3 (en) Compositions comprising 1,1-difluoroethene (r-1132a)
IL241355A0 (en) Pyrazole-amide compounds, preparations containing them and their uses
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
EP2966975A4 (en) POLLINATION ENHANCEMENT COMPOSITIONS AND METHOD FOR THEIR USE
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201320919D0 (en) Composition
GB201320303D0 (en) Composition
GB201317388D0 (en) Composition
GB201306984D0 (en) Composition
GB201322456D0 (en) Radiotracer compositions and methods
GB201322772D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
IL242275B (en) The composition containing hydrocortisone
ZA201505650B (en) New compositions
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201305622D0 (en) Composition
SI2792237T1 (sl) Sestavek, sestava za gojenje in postopek gojenja Spathius exarator